Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study

Clinical trial NCT07163910 · RECRUITING

Trial details

NCT number: NCT07163910
Sponsor: baotai Liang
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2025-04-20
Primary completion: 2027-09-20
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.